To receive our newsletter by mail or email, contact us at gazette@cfsociety.org
The CFS Gazette V1.I2
Check out our newsletter. The CFS Gazette V1.I3
Vertex Pharmaceuticals has picked two cystic fibrosis drugs to test in combination with its existing CF medicine, Kalydeco, as part…
In 2008, Lainie Diamond was living in New York and was wondering where her laughter went. She discovered a yoga…
A collaborative design effort to create a dispensing device for medicines used to treat the genetic disease cystic fibrosis (CF)…
A recent study conducted at the Robarts Research Institute at Western University in London, UK, demonstrated the effectiveness of the…
ProQR Therapeutics B.V., a biopharmaceutical company based in Leiden, Netherlands and founded in 2012, is developing RNA-based therapeutics for the…
Young adults and children with cystic fibrosis in the United States have better lung function than those who live in…
N8 Respiratory LLC, an emerging respiratory therapeutics company focused on treatment of chronic cystic fibrosis pulmonary infections, announced new results…